nicotine has been researched along with Developmental Psychomotor Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, A; Hall, FS; Kasahara, Y; Sora, I; Uchiumi, O; Uhl, GR | 1 |
| Collins, AC; Hutton, SR; Marks, MJ; McCallum, SE; Paylor, R; Tritto, T; Waddle, SA | 1 |
| Brown, RW; Kostrzewa, RM; Thacker, SK; Thompson, KD; Thompson, KN; Ward, JJ; Williams, MT | 1 |
| Abdel-Rahman, A; Abou-Donia, MB; Chen, WC; Dechkovskaia, AM; Guan, X; Khan, WA; Sutton, JM | 1 |
| Elder, JH; Galicia, O; González-Lira, B; Guevara-Martínez, M; Guzmán, K; Montes-Rodríguez, CJ; Prospéro-García, O; Rueda-Orozco, PE | 1 |
| Bunikowski, R; Grimmer, I; Heiser, A; Metze, B; Obladen, M; Schäfer, A | 1 |
6 other study(ies) available for nicotine and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.
Topics: Animals; Behavior, Animal; Cognition Disorders; Crosses, Genetic; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Drug Interactions; Female; Male; Mice; Mice, Knockout; Nerve Tissue Proteins; Neural Inhibition; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Psychomotor Disorders; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists | 2013 |
Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia.
Topics: Animals; Body Temperature; DNA Mutational Analysis; DNA Primers; Gene Deletion; Locomotion; Mice; Mice, Inbred C57BL; Nicotine; Point Mutation; Protein Subunits; Psychomotor Disorders; Receptors, Nicotinic; Sensitivity and Specificity | 2004 |
Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression.
Topics: Acetylcholine; Animals; Animals, Newborn; Behavior, Animal; Brain Chemistry; Brain-Derived Neurotrophic Factor; Choline O-Acetyltransferase; Cognition Disorders; Dopamine Agonists; Enzyme-Linked Immunosorbent Assay; Hippocampus; Humans; Male; Nerve Growth Factor; Nicotine; Nicotinic Agonists; Psychomotor Disorders; Psychomotor Performance; Quinpirole; Rats; Rats, Sprague-Dawley; Reaction Time; Swimming; Time Factors; Yawning | 2004 |
Maternal exposure of rats to nicotine via infusion during gestation produces neurobehavioral deficits and elevated expression of glial fibrillary acidic protein in the cerebellum and CA1 subfield in the offspring at puberty.
Topics: Animals; Cerebellum; Female; Glial Fibrillary Acidic Protein; Hippocampus; Infusion Pumps, Implantable; Male; Maternal Exposure; Nicotine; Nicotinic Agonists; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Disorders; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Sexual Maturation | 2005 |
Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats.
Topics: Animals; Drug Interactions; Electroencephalography; Evoked Potentials, Motor; HIV Envelope Protein gp120; Humans; Male; Nicotine; Nicotinic Agonists; Psychomotor Disorders; Rats; Rats, Wistar; Rotarod Performance Test | 2006 |
Neurodevelopmental outcome after prenatal exposure to opiates.
Topics: Adolescent; Adult; Child Development; Female; Fetus; Humans; Infant; Infant, Newborn; Longitudinal Studies; Narcotics; Nicotine; Pregnancy; Pregnancy Complications; Prospective Studies; Psychomotor Disorders; Socioeconomic Factors; Substance-Related Disorders | 1998 |